Teicoplanin Altan

Teicoplanin Altan is a glycopeptide antibiotic used for treating bacterial infections. This EU-manufactured medication is available for intramuscular or intravenous use. It targets gram-positive bacteria and is commonly prescribed when other antibiotics are unsuitable. Short-term use helps reduce infection risk in certain procedures.

Teicoplanin Altan is prescribed to treat serious bacterial infections caused by susceptible gram-positive organisms. This includes skin and soft tissue infections, bone and joint infections, and lower respiratory tract infections. It is also used to prevent infections in patients undergoing certain surgical procedures, particularly those with a history of penicillin allergy. The medication works by disrupting bacterial cell wall formation.

Teicoplanin Altan works by interfering with the growth of bacteria, helping the body’s immune system to clear the infection. Patients may notice a reduction in fever and symptoms like pain or swelling as the infection begins to resolve. The medication is typically administered in a clinical setting to ensure proper dosing and monitoring.

Teicoplanin Altan should be used with caution in patients with known allergies to glycopeptide antibiotics. It is important to inform healthcare providers about any kidney problems or hearing issues before starting treatment. Regular monitoring may be required during therapy to assess kidney function and hearing. This medication is not suitable for everyone and should only be used under medical supervision.

Teicoplanin Altan may interact with other medications that affect kidney function or hearing, such as certain diuretics or aminoglycosides. Combining it with other antibiotics or drugs that prolong the QT interval could increase the risk of side effects. Alcohol use should be avoided during treatment. Patients should disclose all current medications to their healthcare provider before starting Teicoplanin Altan.